NLM Logo

DAVTHML regimen MeSH Supplementary Concept Data 2024


MeSH Supplementary
DAVTHML regimen
Unique ID
C110618
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C110618
Entry Term(s)
DAVTHML protocol
Registry Number
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Doxorubicin
Fluoxymesterone
Methotrexate
Mitolactol
Tamoxifen
Vincristine
Frequency
1
Note
chemotherapy protocol consisting of above 6 cpds; has been used in therapy of metastatic breast cancer
Source
Am J Clin Oncol 1998 Feb;21(1):99-104
Date of Entry
1998/03/04
Revision Date
2000/11/30
DAVTHML regimen Preferred
DAVTHML protocol Narrower
page delivered in 0.004s